State Of Wyoming Zymeworks Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.82 - $7.7 $2,164 - $3,457	-449 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$6.0 - $16.98 $402 - $1,137	67 Added 17.54%	449 $3,000
Q4 2021 Feb 11, 2022	BUY	$15.19 - $29.33 $470 - $909	31 Added 8.83%	382 $6,000
Q3 2021 Feb 11, 2022	SELL	$27.35 - $37.28 $6,235 - $8,499	-228 Reduced 39.38%	351 $10,000
Q2 2021 Feb 11, 2022	BUY	$26.5 - $38.23 $8,241 - $11,889	311 Added 116.04%	579 $20,000
Q1 2021 Feb 08, 2022	BUY	$29.83 - $56.81 $7,994 - $15,225	268 New	268 $8,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $872M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.